Navigation Links
eCardio Diagnostics Launches Academic Medicine Initiative
Date:3/16/2009

THE WOODLANDS, Texas, March 17 /PRNewswire/ -- eCardio Diagnostics (www.ecardio.com) announced today that the company has launched an Academic Medicine initiative to provide a tailored offering to university-based health systems. It is the first time an arrhythmia monitoring company has addressed the unique workflow, teaching and research responsibilities of academic medical centers.

"At eCardio, we work closely with physicians to develop our products and services," noted Larry Lawson, President and Chief Executive Officer. "Academic medical centers have unique needs related to their teaching and research programs that are not met by traditional monitoring services. In response to that feedback, we have developed the first offering by an arrhythmia monitoring company specifically designed to meet the demands of university-delivered care."

The eCardio Academic Medicine service offers:

  • Unique Web platform to address academic flow for patient management;
  • 24-hour monitoring by eCardio's eLab, an independent diagnostic testing facility; and
  • Complimentary state-of-the-art arrhythmia monitors, including extended monitors, cardiac event monitors and Holter monitors.

To lead this initiative, the company has appointed John Elsholz as Vice President of Academic Medicine. Elsholz has worked in the area of cardiac rhythm management for more than 25 years in both academic and industrial settings. After studying atrial fibrillation in cardiovascular research at the University of Utah, Elsholz worked at Beckman and Space Labs in business and product development with medical scientists in various disciplines. Elsholz later served as Vice President of Engineering at Lumedx and as the Global Director of Cardiovascular Information Systems (CVIS) at GE Medical.

Most recently, Elsholz served as Vice President of Product Development at Witt Biomedical before returning to the University of Utah to direct the acquisition and implementation of informatics for the cardiovascular service line.

About eCardio Diagnostics

eCardio Diagnostics, www.ecardio.com, is the nation's leading provider of comprehensive and advanced technologies, devices, services and solutions for the diagnosis, monitoring and subsequent clinical management of cardiac arrhythmias, predominantly in the ambulatory setting. eCardio provides leading-edge diagnostic innovations and solutions that optimize the flexibility, speed and accuracy of cardiac arrhythmia diagnoses--contributing to the timeliest, most effective and appropriate management of cardiac patients.


'/>"/>
SOURCE eCardio Diagnostics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference
2. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
3. Hypertension Diagnostics Announces Fiscal Year 2007 Results
4. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
5. Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
6. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
7. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
8. HealthShares(TM) Announces Changes to the HealthShares(TM) Diagnostics and Composite Indexes
9. Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations
10. Quest Diagnostics Reports Third Quarter Results
11. ICx Technologies and Siemens Medical Solutions Diagnostics Enter In Vitro Diagnostics Development and License Option Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, is ... to take the Diabetes Risk Test to find out if they are at risk ... Airports will light up the evening sky by programming the LAX pylons the color ...
(Date:3/28/2017)... YORK (PRWEB) , ... March 28, 2017 , ... ... NTX Technology™, is the first technology to directly address the resolution to globally ... NTX Technology™ is a patented compound of FDA and TTB approved ingredients that ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, ... be invited to the Siemens Healthineers annual customer education symposium, a world-class learning ... take place from March 27 - 31, 2017 at the Atlanta Marriott Marquis ...
(Date:3/28/2017)... ... March 29, 2017 , ... The Thyroid Secret is ... Pharm.D., FASCP. The program was recently launched on March 1, and Dr. Wentz ... function. , Dr. Izabella Wentz is a licensed pharmacist and a foremost ...
(Date:3/28/2017)... ... March 28, 2017 , ... City trips have soared 82% ... Trends Report). As travelers visit both urban destinations, they are faced with exploration ... exposure. In response, the outdoor industry has blurred the lines between fashion and ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... SPRING, Md. , March 28, 2017 /PRNewswire-USNewswire/ ... approved Dupixent (dupilumab) injection to treat adults with ... patients whose eczema is not controlled adequately by ... are not advisable. Dupixent can be used with ... of Dupixent demonstrates our commitment to approving new ...
(Date:3/28/2017)... LONDON , March 28, 2017  "US ... insight on the various indicators and trend analysis ... generics drugs in mainstream pharmaceutical market in US. ... responsible for the growth on cancer generics drugs ... resulted in saving of billions of dollars for ...
(Date:3/28/2017)... PHOENIX , March 28, 2017  Today, Allergy ... released a new white paper to underscore the ... latex in healthcare. Specifically, there is substantial confusion as to ... FDA has urged manufacturers to drop the term "latex free" ... of the challenge to ensure a product is completely devoid ...
Breaking Medicine Technology: